|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Proinsulin (Intact) LUM Assay | Bevacizumab (Avastin®) ELISA | Insulin IRMA Assay | Noradrenaline high sensitive research ELISA | SCC ELISA Assay |
| Citations | | | | | |
| Catalog Number | IV2-002 | TM09010 | KIP1251 | IB89537R | 800-85 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro diagnostics.... Read More | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Immunoradiometric assay (RIA) for the quantitative determination of human Insulin (INS) in serum. FDA exempt, can be used for in-vitro diagnostics. | Enzyme Immunoassay for the determination of Noradrenaline (Norepinephrine). Flexible test system for various biological types and volumes.
Noradrenaline (norepinephrine) is extracted by using a cis-diol-specific affinity gel, acylated, and then converted enzymatically.
The competitive ELISA Enzyme Immunoassay for the determination of Noradrenaline (Norepinephrine). Flexible test system for various biological types and volumes.
Noradrenaline (norepinephrine) is extracted by using a cis-diol-specific affinity gel, acylated, and then converted enzymatically.
The competitive ELISA kit uses the microtiter plate format.... Read More | Enzyme immunoassay (ELISA) for the determination of squamous cell carcinoma (SCC) antigen in serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | IGFBP-3 | Bevacizumab (Avastin®) | Leptin | GIP | Complement System Classical Pathway |
| Sample Type | Serum, Blood Plasma, Follicular Fluid, Seminal Blood Plasma | Serum and plasma. | Serum, Blood Plasma, Urine, Saliva | Blood Plasma, Cell Culture Supernatant | Serum |
| Method | Luminescence (LUM) Assay | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.5 to 110.0 pmol/L | 0 / 6 to 200 ng/mL | 5.7 to 440 µIU/mL | 0.2 to 32 ng/mL. Note: The concentrations of the unknowns taken from the calibrator curve have to be multiplied by a correction factor. | 0.3 to 50 µg/L |
| Sensitivity | 0.5 ng/mL | 2 ng/mL | 1.0 ng/mL | 0.82 pmol/L | Inquire |
| Assay Time | 3 hrs (incubation) | 1 hour, 45 min. total incubation time. | 2 hrs (incubation) | 4 hrs 25 min (incubation) | 1 hrs 30 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |